Centro di Riferimento Oncologico
In research, Centro di Riferimento Oncologico stands highest in Medicine (#3,139 of 10,443 worldwide) and Health Sciences (#4,223 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 14.1× its share of world research.
- World rank, 2022–2025
- #8,452 of 28,054 · #6,346 all time
- Rank in Italy
- #242 of 618
- Research works
- 2.6k ▼ 4% vs 2013–17
- Citations
- 75k 28.6 per fractional work
- Top-10% rate
- 22.1% record average 16.5%
- Open access
- 36% world 28%
What is Centro di Riferimento Oncologico known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,139 of 10,443 | 21.9% | 163 | #1772 | |
| Health SciencesDomain | #4,223 of 11,982 | 21.9% | 169 | #2259 |
Each strip is that field’s whole ranked pool, with the notch where Centro di Riferimento Oncologico sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Centro di Riferimento Oncologico specialise in?
Where its research is concentrated relative to its size: Oncology takes 14.1× the share of its output that it takes of world research.
- OncologySubfield · 40.2 works14×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.4×. Every wedge is a field page.
- Immunology and Microbiology 3.4×
- Biochemistry, Genetics and Molecular Biology 3.3×
- Medicine 3.3×
- Pharmacology, Toxicology and Pharmaceutics 1.7×
- Dentistry 1.4×
- Nursing 1.2×
- Chemistry 1.1×
- Economics, Econometrics and Finance 0.5×
- Health Professions 0.4×
- Neuroscience 0.4×
- Materials Science 0.3×
- Physics and Astronomy 0.3×
- Psychology 0.3×
- Engineering 0.2×
- Mathematics 0.2×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Earth and Planetary Sciences 0.1×
- Computer Science 0.1×
- Decision Sciences 0.1×
- Chemical Engineering 0.0×
- Arts and Humanities 0.0×
- Energy 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Centro di Riferimento Oncologico?
Ranked on the composite score, Silvia Franceschi, Annunziata Gloghini and Renato Talamini lead among researchers whose main affiliation is Centro di Riferimento Oncologico.
- 1 Silvia Franceschi Italy · #2,091 worldwide 1.2k citations · 156 works
- 2 Annunziata Gloghini Italy · #38,883 worldwide 334 citations · 61 works
- 3 Renato Talamini Italy · #49,149 worldwide 331 citations · 74 works
- 4 Luigino Dal Maso Italy · #54,572 worldwide 297 citations · 42 works
- 5 Alessandra Bearz Italy · #63,523 worldwide 204 citations · 45 works
- 6 Roberto Sorio Italy · #73,789 worldwide 296 citations · 37 works
- 7 Antonino Carbone Italy · #95,630 worldwide 461 citations · 141 works
- 8 Diego Serraino Italy · #95,981 worldwide 294 citations · 91 works
- 9 Flavio Rizzolio Italy · #98,020 worldwide 361 citations · 27 works
- 10 Jerry Polesel Italy · #103,377 worldwide 202 citations · 49 works
Which keywords describe research at Centro di Riferimento Oncologico?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Cancer, Prognostic Factors, Clinical Trials, Targeted Therapy, Clinical Practice Guidelines, Breast Cancer and Rituximab.
- Treatment Guidelines
- Genomic Aberrations
- Hodgkin's Lymphoma
- Mutational Signatures
- Cancer Genomics
- Cancer Incidence
- Gene Expression Profiling
- Metastatic Breast Cancer
- Molecular Profiling
- Molecular Subtypes
- Precision Medicine
- Tumor Microenvironment
- Survival Analysis
- Quality of Life
- Metastasis
- Rituximab
- Clinical Practice Guidelines
- Inflammation
- Prognostic Factors
- Cancer
- Chemotherapy
- Epidemiology
- Clinical Trials
- Targeted Therapy
- Breast Cancer
- Immunotherapy
- Biomarkers
- Radiotherapy
- PET Imaging
- Cancer Therapy
- Lymphoma
- Neoadjuvant Therapy
- Gene Expression
- Therapeutic Targets
- Genomic Instability
- Genomic Profiling
- Cell-Free DNA
- Genetic Pathogenesis
- Chronic Lymphocytic Leukemia
- Cetuximab
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy26▲ 15×21 topics
- Cancer20▲ 5.9×37 topics
- Epidemiology15▲ 1.53×66 topics
- Prognostic Factors15▲ 13×14 topics
- Clinical Trials14▲ 8.0×16 topics
- Inflammation14▲ 2.6×54 topics
- Targeted Therapy13▲ 23×5 topics
- Clinical Practice Guidelines12▲ 8.8×11 topics
- Breast Cancer12▲ 20×11 topics
- Rituximab12▲ 32×4 topics
- Immunotherapy12▲ 6.6×16 topics
- Metastasis11▲ 13×10 topics
- Biomarkers11▲ 6.2×13 topics
- Quality of Life10▲ 2.8×30 topics
- Radiotherapy10▲ 10×12 topics
- Survival Analysis10▲ 14×6 topics
- PET Imaging9▲ 22×4 topics
- Tumor Microenvironment9▲ 7.9×8 topics
- Cancer Therapy8▲ 5.7×15 topics
- Precision Medicine8▲ 6.9×6 topics
- Lymphoma8▲ 18×4 topics
- Molecular Subtypes7▲ 34×3 topics
- Neoadjuvant Therapy7▲ 12×5 topics
- Molecular Profiling7▲ 28×3 topics
- Gene Expression7▲ 4.5×9 topics
- Metastatic Breast Cancer7▲ 48×2 topics
- Therapeutic Targets7▲ 18×7 topics
- Gene Expression Profiling7▲ 32×2 topics
- Genomic Instability7▲ 24×3 topics
- Cancer Incidence6▲ 19×4 topics
- Genomic Profiling6▲ 24×2 topics
- Cancer Genomics6▲ 33×1 topic
- Cell-Free DNA6▲ 24×2 topics
- Mutational Signatures6▲ 33×1 topic
- Genetic Pathogenesis6▲ 44×1 topic
- Hodgkin's Lymphoma6▲ 44×1 topic
- Chronic Lymphocytic Leukemia6▲ 51×1 topic
- Genomic Aberrations6▲ 51×1 topic
- Cetuximab5▲ 26×2 topics
- Treatment Guidelines5▲ 9.5×4 topics
Which research topics does Centro di Riferimento Oncologico publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Lung Cancer Treatments and Mutations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 6 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 6 works
- 3 Chronic Lymphocytic Leukemia Research Genetics 6 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 5 works
- 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 4 works
- 6 Colorectal Cancer Treatments and Studies Oncology 4 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 8 Ovarian cancer diagnosis and treatment Reproductive Medicine 3 works
- 9 Breast Cancer Treatment Studies Cancer Research 3 works
- 10 Cancer Treatment and Pharmacology Oncology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Centro di Riferimento Oncologico's research output changed?
Output in 2018–2022 was 4% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.